Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19
Clinical trial NCT04456361 · UNKNOWN
Trial details
- NCT number
- NCT04456361
- Sponsor
- Instituto de Medicina Regenerativa
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-16
- Primary completion
- 2025-02-15
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.